Week 2 - SCI Risk Assessment

Week 2 - SCI Risk Assessment - Risk Assessment 1 Risk...

Info iconThis preview shows pages 1–4. Sign up to view the full content.

View Full Document Right Arrow Icon
Risk Assessment 1 Risk Assessment Eric DeMent University of Phoenix
Background image of page 1

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Risk Assessment 2 Risk Assessment Outline I. Hazard Identification A. Short-term effects 1. Headaches, nausea, dizziness, weakness, cramps, diarrhea, excessive sweating, blurred vision and increased heart rate B. Long-term effects 1. No proof of any long-term health effects to humans II. Dose-Response A. Low dose 1. No evidence of any low dose responses B. High Dose 2. Headaches, nausea, dizziness, weakness, cramps, diarrhea, excessive sweating, blurred vision and increased heart rate III. Exposure A. The longer someone is around Malathion, the higher risk of health effects B. There is no evidence of any humans being tested to determine what dose? How often? or How long? IV. Risk Characterization A. The probability of a person or population of getting health effects from Malathion, according to U.S. Environmental Protection Agency, is extremely low.
Background image of page 2
Risk Assessment 3 Risk Assessment Vote Many people have speculated about using the mosquito controlling pesticide known as Malathion. Some fear that the city should not use pesticides to control mosquitoes. I assure the
Background image of page 3

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
Image of page 4
This is the end of the preview. Sign up to access the rest of the document.

Page1 / 5

Week 2 - SCI Risk Assessment - Risk Assessment 1 Risk...

This preview shows document pages 1 - 4. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online